Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy-Reference-Cited by-同舟云学术

Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy

Published:2021-01-01 Issue:1 Volume:12 Page:2095-2105
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Tang Qu-Lai¹,Gu Li-Xing²,Xu Yao²,Liao Xing-Hua²,Zhou Yong²,Zhang Tong-Cun¹^ORCID

Affiliation:

1. Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education & Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China

2. College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, Hubei, China

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1931644

Reference35 articles.

1. Challenges of up-scaling lentivirus production and processing

2. How far have we explored fungi to fight cancer?

3. RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope

4. A 3D Sphere Culture System Containing Functional Polymers for Large-Scale Human Pluripotent Stem Cell Production

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic alteration of SJ293TS cells and modification of serum-free media enhances lentiviral vector production;Molecular Therapy - Methods & Clinical Development;2024-06

2. Advanced Systems and Bioreactors for Large-Scale Secondary Metabolite Production in Medicinal Plants Using Suspension Cultured Cells;Biosynthesis of Natural Products in Plants;2024

3. Optimizing VLP production in gene therapy: Opportunities and challenges for in silico modeling;Biotechnology Journal;2023-05-13

4. Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies;Bioengineering;2022-12-15